Uloric and Indapamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Uloric (febuxostat) and Indapamide (indapamide). Common drug interactions include adverse event among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Uloric and Indapamide. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Uloric?

Uloric has active ingredients of febuxostat. It is often used in gout. eHealthMe is studying from 8,067 Uloric users. Check the latest studies of Uloric.

What is Indapamide?

Indapamide has active ingredients of indapamide. It is often used in high blood pressure. eHealthMe is studying from 22,152 Indapamide users. Check the latest studies of Indapamide.



On Jul, 07, 2026

32 people who take Uloric and Indapamide together, and have interactions are studied.

Uloric and Indapamide drug interactions.

What are the common drug interactions of Uloric and Indapamide, by gender? *:

female:

  1. Adverse event
  2. Blood urea nitrogen/creatinine ratio increased
  3. Calcinosis (calcium deposits in any soft tissue)
  4. Cystitis (inflammation of the wall of the bladder)
  5. Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
  6. Diarrhoea
  7. Drug ineffective
  8. Exostosis (formation of new bone on the surface of a bone)
  9. Eye swelling
  10. Eyelid ptosis (falling of the upper or lower eyelid)

male:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)
  3. Lethargy (tiredness)
  4. Acne (skin problems that cause pimples)
  5. Arthropathy
  6. Bacterial infection
  7. Blood glucose increased
  8. Blood pressure decreased
  9. Chills (felling of cold)
  10. Chronic kidney disease

What are the common drug interactions of Uloric and Indapamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)
  3. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

60+:

  1. Pain
  2. Lethargy (tiredness)
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Cystitis (inflammation of the wall of the bladder)
  5. Diarrhoea
  6. Discomfort
  7. Drug ineffective
  8. Exostosis (formation of new bone on the surface of a bone)
  9. Fatigue (feeling of tiredness)
  10. Heart rate increased

What are the existing conditions these people have? *

  1. Diabetes: 5 people, 15.62%
  2. Vasculitis (inflammation of a blood vessel or blood vessels): 4 people, 12.50%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 12.50%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 12.50%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 9.38%
  6. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 6.25%
  7. Pain: 2 people, 6.25%
  8. Homocystinuria (inherited disorder in which the body is unable to process certain building blocks of proteins (amino acids) properly): 2 people, 6.25%
  9. High Blood Cholesterol: 2 people, 6.25%
  10. Haematological Malignancy (cancer that affect blood, bone marrow, and lymph nodes): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Uloric and Indapamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Uloric and Indapamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Uloric:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Indapamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Uloric and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Indapamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on febuxostat and indapamide (the active ingredients of Uloric and Indapamide, respectively), and Uloric and Indapamide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: